Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preparing for the Final Phase of Hepatitis C Elimination in Cairns: An Implementation Trial of a Test and Treat Approach to Reach the Final 30%.

NCT05264558 is registered in ClinicalTrials.gov with Macfarlane Burnet Institute for Medical Research and Public Health Ltd as lead sponsor.

NCT NCT05264558
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05264558 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preparing for the Final Phase of Hepatitis C Elimination in Cairns: An Implementation Trial of a Test and Treat Approach to Reach the Final 30%.
Lead sponsor
Macfarlane Burnet Institute for Medical Research and Public Health Ltd
Phase
Phase 4
Overall status
Completed
Start date
July 25, 2022
Completion date
September 30, 2023
Enrollment
606 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c